Agilent to buy pathology software maker Proscia for $240 million

Oct 13 (Reuters) - ‌Agilent Technologies ​said ​on Tuesday it would acquire pathology software maker Proscia for $240 ‌million in cash, plus up to $30 ⁠million tied to future performance targets, as ‌the laboratory equipment ‌maker expands its push into AI-enabled diagnostics.

Here are some more details:

• Privately ​held Proscia develops software that converts pathology slides into digital images ⁠that can be stored, reviewed and analyzed using ​artificial intelligence tools

• Agilent said the acquisition would strengthen its pathology ​business and expand its ‌presence in digital and AI-enabled diagnostics

• The deal would ⁠provide Agilent access to a high-growth software business that generated more than $18 million ⁠in revenue over the past 12 months

• The ​companies have worked together since 2022, when they entered a multi-year distribution agreement to ‌offer a digital pathology system combining Agilent's pathology products with ‌Proscia's software

• The deal is ⁠expected to close ‌early in Agilent's ​fiscal 2027

(Reporting by Siddhi Mahatole in Bengaluru; Editing by Aseem ‌Gujar)

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Freshworks (FRSH) Reiterated at Overweight by Cantor Fitzgerald on Agreement to Acquire Torii
• Goldman Sachs beats third quarter estimates on trading strength
• Salesforce shares jump on Bank of America double upgrade